retail news in context, analysis with attitude

Reuters reports that US regulators are warming to the notion that cholesterol-lowering drugs should be switched from being prescription-only to over-the-counter status.

Such a switch is scheduled to happen soon in the UK.

Cholesterol-lowering medications such as Lipitor and Zocor are among the world’s most popular and profitable drugs, and the US Food and Drug Administration (FDA) has become more amenable of late to such switches from Rx to OTC. Four years ago, FDA blocked a switch that was proposed for Merck's Mevacor and Bristol-Myers Squibb's Pravachol, but it is generally believed that the government would rule differently today.

The Bush Administration has called for such switches as a way of reducing the cost of prescription drugs in the US.
KC's View:
Get ready for some new planograms and to clear off some room on the HBC shelves. When this happens, it is going to be huge.